1. Home
  2. AMR vs IOVA Comparison

AMR vs IOVA Comparison

Compare AMR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Metallurgical Resources Inc.

AMR

Alpha Metallurgical Resources Inc.

HOLD

Current Price

$183.27

Market Cap

2.0B

Sector

Energy

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.21

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMR
IOVA
Founded
2016
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
968.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMR
IOVA
Price
$183.27
$2.21
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$168.00
$10.36
AVG Volume (30 Days)
252.3K
9.8M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,226,356,000.00
$250,425,000.00
Revenue This Year
N/A
$60.94
Revenue Next Year
$17.77
$60.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
175.62
52 Week Low
$97.41
$1.64
52 Week High
$233.20
$8.56

Technical Indicators

Market Signals
Indicator
AMR
IOVA
Relative Strength Index (RSI) 59.93 46.56
Support Level $170.13 $2.18
Resistance Level $185.77 $2.32
Average True Range (ATR) 8.79 0.12
MACD 2.35 -0.01
Stochastic Oscillator 79.71 18.11

Price Performance

Historical Comparison
AMR
IOVA

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: